These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12429645)

  • 1. Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors.
    Bello L; Giussani C; Carrabba G; Pluderi M; Lucini V; Pannacci M; Caronzolo D; Tomei G; Villani R; Scaglione F; Carroll RS; Bikfalvi A
    Clin Cancer Res; 2002 Nov; 8(11):3539-48. PubMed ID: 12429645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.
    Bello L; Lucini V; Costa F; Pluderi M; Giussani C; Acerbi F; Carrabba G; Pannacci M; Caronzolo D; Grosso S; Shinkaruk S; Colleoni F; Canron X; Tomei G; Deleris G; Bikfalvi A
    Clin Cancer Res; 2004 Jul; 10(13):4527-37. PubMed ID: 15240545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
    Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term inhibition of glioma growth by systemic administration of human PEX.
    Pluderi M; Lucini V; Caronzolo D; Pannacci M; Costa F; Carrabba G; Giussani C; Grosso S; Colleoni F; Scaglione F; Villani R; Bikfalvi A; Bello L
    J Neurosurg Sci; 2003 Jun; 47(2):69-78. PubMed ID: 14618134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo.
    Giussani C; Carrabba G; Pluderi M; Lucini V; Pannacci M; Caronzolo D; Costa F; Minotti M; Tomei G; Villani R; Carroll RS; Bikfalvi A; Bello L
    Cancer Res; 2003 May; 63(10):2499-505. PubMed ID: 12750272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
    Bello L; Lucini V; Carrabba G; Giussani C; Machluf M; Pluderi M; Nikas D; Zhang J; Tomei G; Villani RM; Carroll RS; Bikfalvi A; Black PM
    Cancer Res; 2001 Dec; 61(24):8730-6. PubMed ID: 11751392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.
    Kim SK; Cargioli TG; Machluf M; Yang W; Sun Y; Al-Hashem R; Kim SU; Black PM; Carroll RS
    Clin Cancer Res; 2005 Aug; 11(16):5965-70. PubMed ID: 16115940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model.
    Benny O; Kim SK; Gvili K; Radzishevsky IS; Mor A; Verduzco L; Menon LG; Black PM; Machluf M; Carroll RS
    FASEB J; 2008 Feb; 22(2):488-99. PubMed ID: 17873103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.
    Sathornsumetee S; Hjelmeland AB; Keir ST; McLendon RE; Batt D; Ramsey T; Yusuff N; Rasheed BK; Kieran MW; Laforme A; Bigner DD; Friedman HS; Rich JN
    Cancer Res; 2006 Sep; 66(17):8722-30. PubMed ID: 16951188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
    Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
    Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transplantation and magnetic resonance imaging of transplantable human glioma tissue in the brain of nude mice].
    Li RJ; Diao Y; Huang Q; Shen JK; Lan Q
    Ai Zheng; 2007 Sep; 26(9):937-41. PubMed ID: 17927848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using behavioral measurement to assess tumor progression and functional outcome after antiangiogenic treatment in mouse glioma models.
    Yang H; Chopp M; Zhang X; Jiang F; Zhang Z; Kalkanis S; Schallert T
    Behav Brain Res; 2007 Aug; 182(1):42-50. PubMed ID: 17572515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
    Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
    J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of recombinant human lymphotoxin on a tumor line of human malignant glioma.
    Mikami T; Kurisu K; Kiya K; Mukada K; Kawamoto K; Hotta T; Uozumi T
    Hiroshima J Med Sci; 1989 Sep; 38(3):103-7. PubMed ID: 2584052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
    Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
    Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.